WO1998042277A1 - Extenseur intravasculaire - Google Patents

Extenseur intravasculaire Download PDF

Info

Publication number
WO1998042277A1
WO1998042277A1 PCT/US1998/005835 US9805835W WO9842277A1 WO 1998042277 A1 WO1998042277 A1 WO 1998042277A1 US 9805835 W US9805835 W US 9805835W WO 9842277 A1 WO9842277 A1 WO 9842277A1
Authority
WO
WIPO (PCT)
Prior art keywords
expansion
stent
column
strut
struts
Prior art date
Application number
PCT/US1998/005835
Other languages
English (en)
Inventor
G. David Jang
Original Assignee
Jang G David
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/824,865 external-priority patent/US6152957A/en
Priority claimed from US08/824,142 external-priority patent/US6241760B1/en
Application filed by Jang G David filed Critical Jang G David
Priority to AU65839/98A priority Critical patent/AU6583998A/en
Priority to JP54594498A priority patent/JP4046773B2/ja
Priority to EP98912026A priority patent/EP0971644A1/fr
Publication of WO1998042277A1 publication Critical patent/WO1998042277A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958—Inflatable balloons for placing stents or stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155—Adjacent bands being connected to each other
    • A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004—Rounded shapes, e.g. with rounded corners
    • A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility

Definitions

  • This invention relates to intravascular stents, and more particularly to an intravascular stent which provides easy introduction through tortuous sections of vessels.
  • Angioplasty either coronary or general vascular
  • Balloon catheter dependent angioplasty has consistently proven to be the most reliable and practical interventional procedure.
  • Other ancillary technologies such as laser based treatment, or directional or rotational arthrectomy, have proven to be either of limited effectiveness or dependent on balloon angioplasty for completion of the intended procedure. Restenosis following balloon-based angioplasty is the most serious drawback and is especially prevalent in the coronary artery system.
  • Intravascular stenting noticeably reduces the restenosis rate following angioplasty procedures.
  • the procedure for intravascular stent placement typically involves pre-dilation of the target vessel using balloon angioplasty, followed by deployment of the stent, and expansion of the stent such that the dilated vessel walls are supported from the inside.
  • the intravascular stent functions as scaffolding for the lumen of a vessel.
  • the scaffolding of the vessel walls by the stent serve to: (a) prevent elastic recoil of the dilated vessel wall, (b) eliminate residual stenosis of the vessel; a common occurrence in balloon angioplasty procedures, ⁇ maintain the diameter of the stented vessel segment slightly larger than the native unobstructed vessel segments proximal and distal the stented segment and (d) as indicated by the latest clinical data, lower the restenosis rate.
  • the restenosis rate of stented vessels has proven significantly lower than for unstented or otherwise treated vessels; treatments include drug therapy and other methods mentioned previously.
  • Stenting has proven to be effective in some cases for treating impending closure of a vessel during angioplasty. Stenting can also control and stabilize an unstable local intimal tear of a vessel caused by normal conduct during an angioplasty procedure. In some cases, an incomplete or less than optimal dilatation of a vessel lesion with balloon angioplasty can successfully be opened up with a stent implant.
  • a conventional stent patent is US 5,102,417 (hereafter the Palmaz Patent).
  • the stent described in the Palmaz Patent consists of a series of elongated tubular members having a plurality of slots disposed substantially parallel to the longitudinal axis of the tubular members.
  • the tubular members are connected by at least one flexible connector member.
  • the unexpanded tubular members of the Palmaz Patent are overly rigid so that practical application is limited to short lengths. Even with implementation of the multilink design with flexible connector members connecting a series of tubular members, longer stents can not navigate tortuous blood vessels. Furthermore, the rigidity of the unexpanded stent increases the risk of damaging vessels during insertion. Foreshortening of the stent during insertion complicates accurate placement of the stent and reduces the area that can be covered by the expanded stent. There is, further, no method of programming the stent diameter along its longitudinal axis to achieve a tapered expanded stent, and no method of reenforcement of stent ends or other regions is provided for.
  • WO 96/03092 Another example of a conventional stent patent is WO 96/03092, the Brun patent.
  • the stent described in the Brun patent is formed of a tube having a patterned shape, which has first and second meander patterns.
  • the even and odd first meander patterns are 180 degrees out of phase, with the odd patterns occurring between every two even patterns.
  • the second meander patterns run perpendicular to the first meander patterns, along the axis of the tube.
  • Adjacent first meander patterns are connected by second meander patterns to form a generally uniform distributed pattern.
  • the symmetrical arrangement with first and second meander patterns having sharp right angled bends allows for catching and snagging on the vessel wall during delivery.
  • the large convolutions in the second meander pattern are not fully straightened out during expansion reducing rigidity and structural strength of the expanded stent.
  • no method of programming the stent diameter along its longitudinal axis to achieve a tapering stent design, and no method of reenforcement of stent ends or other regions is provided for.
  • a stent with sufficient longitudinal flexibility in the unexpanded state to allow for navigation through tortuous vessels.
  • a stent that is structurally strong in the unexpanded state such that risk of damage or distortion during delivery is minimal.
  • a stent that is configured to expand to variable diameters along its length, such that a taper can be achieved in the expanded stent to match the natural taper of the target vessel.
  • an object of the present invention is to provide a scaffold for an interior lumen of a vessel.
  • Another object of the invention is to provide a stent which prevents recoil of the vessel following angioplasty.
  • a further object of the invention is to provide a stent that maintains a larger vessel lumen compared to the results obtained only with balloon angioplasty.
  • Yet another object of the invention is to provide a stent that reduces foreshortening of a stent length when expanded.
  • Another object of the invention is to provide a stent with increased flexibility when delivered to a selected site in a vessel.
  • Another object of the invention is to provide a chain mesh stent that reduces vessel "hang up" in a tortuous vessel or a vessel with curvature.
  • a stent in a non- expanded state with a first column expansion strut pair A plurality of the first column expansion strut pair form a first expansion column. A plurality of second column expansion strut pair form a second expansion column. A plurality of first serial connecting struts form a first connecting strut column that couples the first expansion column to the second expansion column.
  • the first expansion column, the second expansion column, and the first connecting strut column form a plurality of geometric cells. At least a portion of the plurality are asymmetrical geometric cells.
  • At least a portion of the first connecting struts include a proximal section, a distal section a first linear section and a first slant angle.
  • a first expansion strut in the first expansion column is circumferentially offset from a corresponding second expansion strut in the second expansion column.
  • Fig. 1A is a side elevation view of the pre-expansion mode of an embodiment of the stent of the present invention
  • Fig. IB is a cross sectional view of an embodiment of the stent of the present invention.
  • Fig. 1C is a longitudinal cross sectional view of an embodiment of the stent of the present invention.
  • Fig. 2A is a scale drawing of the strut pattern of an embodiment of the stent of the present invention.
  • Fig. 2B is an expanded view of a section of the pattern of Figure 2 A.
  • Fig. 3 A is a schematic illustration of a the pre-expansion mode of an embodiment of the stent of the present invention.
  • Fig. 3B is a schematic illustration of the post-expansion mode of an embodiment of the stent of the present invention.
  • Fig. 4A is a scale drawing including dimensions of an embodiment of the stent of the present invention.
  • Fig. 4B is an enlarged section of the scale drawing of Figure 4A.
  • Fig. 5 is a scale drawing of an embodiment of the stent of the present invention with a tapered diameter in its post-expansion mode.
  • Fig. 6A is a scale drawing of an embodiment of the stent of the present invention with reenforcment expansion columns.
  • Fig. 6B is a perspective view of the embodiment of Figure 6A.
  • Fig. 7 A is a scale drawing of an embodiment of the stent of the present invention including relief notches at strut joints to increase flexibility of the joints..
  • Fig. 7B is an enlarged region of the embodiment of Figure 7A.
  • Fig. 7C is an enlarged view of a single connecting strut joining two expansion strut pairs in accordance with the embodiment of Figure 7A.
  • Fig. 8 A is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • Fig. 8B is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • Fig. 8C is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • Fig. 8D is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • Fig. 8E is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • Fig. 9 is a delivery balloon catheter, illustrating a method of deliver of a stent in accord with the present invention.
  • FIG. 1 A A first embodiment of the present invention is shown in Figures 1 A, IB, 1C, 2 A and 2B.
  • FIG 1 A an elongate hollow tubular stent 10 in an unexpanded state is shown.
  • a proximal end 12 and a distal end 14 define a longitudinal length 16 of stent 10.
  • the longitudinal length 16 of the stent 10 can be as long as 100 mm or longer.
  • a proximal opening 18 and a distal opening 20 connect to an inner lumen 22 of stent 10.
  • Stent 10 can be a single piece, without any seams or welding joints or may include multiple pieces.
  • Stent 10 is constructed of two to fifty or more expansion columns or rings 24 connected together by interspersed connecting strut columns 26. The first column on the proximal end 12 and the last column on the distal end 14 of stent 10 are expansion columns 24.
  • Expansion columns 24 are formed from a series of expansion struts 28, and joining struts 30.
  • Expansion struts 28 are thin elongate members arranged so that they extend at least in part in the direction of the longitudinal axis of stent 10. When an outward external force is applied to stent 10 from the inside by an expansion balloon or other means, expansion struts 28 are reoriented such that they extend in a more circumferential direction, i.e along the surface of cyllindrical stent 10 and perpendicular to its longitudinal axis. Reorientation of expansion struts 28 causes stent 10 to have an expanded circumference and diameter.
  • expansion struts 28 of unexpanded stent 10 are seen to extend substantially parallel to the longitudinal axis of stent 10.
  • Expansion struts 28 are joined together by joining struts 30 to form a plurality of expansion strut pairs 32. Expansion strut pairs have a closed end 34 and an open end 36. Additional joining struts 30 join together expansion struts
  • Each expansion column 24 contains a plurality, typically eight to twenty, twenty to sixty, or larger of expansion struts 28.
  • Connecting struts 38 connect adjacent expansion columns 24 forming a series of interspersed connecting strut columns 26 each extending around the circumference of stent 10.
  • Each connecting strut 38 joins a pair of expansion struts 28 in an expansion column 24 to an adjacent pair of expansion struts 28 in an adjacent expansion column 24.
  • the ratio of expansion struts 28 in an expansion column 24 to connecting struts 38 in a connecting strut column 26 is two to one; however, this ratio in general can be x to 1 where x is greater or less than two. Furthermore, since the stent 10 of Figure 1 A begins with an expansion column 24 on the proximal end 12 and ends with an expansion column 24 on the distal end 14, if there are n expansion columns 24 with m expansion struts 28 per column, there will be m-1 connecting strut columns 26, and n(m-l)/2 connecting struts 38.
  • connecting struts 38 in each connecting strut column 26, as compared to expansion struts 28 in each expansion column 24, allows stent 10 to be longitudinally flexibility. Longitudinal flexibility can be further increased by using a narrow width connecting strut, providing additional flexibility and suppleness to the stent as it is navigated around turns in a natural blood vessel.
  • a cell space is an empty region on the surface of stent 10, completed surrounded by one or a combination of stent struts, including expansion struts 28, connecting struts 38, or joining struts 30.
  • Asymmetrical cell spaces 40 are cell spaces which have no geometrical symmetry i.e. no rotation, reflection, combination rotation and reflection or other symmetry.
  • Asymmetrical cell spaces 40 in Figure 1 A are surrounded by a first expansion strut pair 32 in a first expansion column 24, a first connecting strut
  • expansion strut pairs 32 of asymmetrical cell space 40 may be circumferentially offset i.e. have longitudinal axes that are not collinear and have their open ends 36 facing each other.
  • the space between two expansion struts of an expansion strut pair 32 is known as a loop slot 42.
  • Figure IB shows inner lumen 22, radius 44 and stent wall 46 of stent 10.
  • Stent wall 46 consists of stent struts including expansion struts 28, connecting struts 38 and joining struts 30.
  • Figure 1C shows, proximal end 12, distal end 14, longitudinal length 16, inner lumen 22, and stent wall 46 of stent 10.
  • Inner lumen 22 is surrounded by stent wall 46 which forms the cyllindrical surface of stent 10.
  • joining struts 30 of stent 10 are seen to extend at an angle to the expansion struts 28, forming a narrow angle 48 with one expansion strut 28 in an expansion strut pair 32 and a wide angle 50 with the other expansion strut 28 of an expansion strut pair 32.
  • Narrow angle 48 is less than ninety degrees
  • wide angle 50 is greater than ninety degrees.
  • Joining struts 30 extend both longitudinally along the longitudinal axis of stent 10 and circumferentially, along the surface of the stent 10 perpendicular its longitudinal axis.
  • Expansion strut spacing 52 between adjacent expansion struts 28 in a given expansion column 24 are uniform in stent 10 of Figures 2 A and 2B; however, non-uniform spacings can also be used. Expansion strut spacings 52 can be varied, for example, spacings 52 between adjacent expansion struts 28 in an expansion column 24 can alternate between a narrow and a wide spacing. Additionally, spacings 52 in a single expansion column 24 can differ from other spacings 52 in other columns 24.
  • loop slots 42 results in variable loop slot widths.
  • the longitudinal axis of the loop slots 42 need not be collinear or even parallel with the longitudinal axis of loop slots 42 of an adjacent expansion column 24.
  • Figures 2A and 2B show an arrangement of expansion struts 28 such that collinear, parallel adjacent loop slots 42 are formed, but non-collinear and non-parallel loop slots 42 can also be used. Additionally the shape of loop slots 42 need not be the same among loop slots of a single or multiple expansion columns 24.
  • a loop slots 42 can be altered by changing the orientation or physical dimensions of the expansion struts 28 and/or joining struts 30 which connect expansion struts 28 of expansion strut pairs 32 defining the boundaries of loop slots 42.
  • Connecting struts 38 couple adjacent expansion columns 24, by connecting the distal end of an expansion strut pair in one expansion column 24 to the proximal end of an adjacent expansion strut pair 32 in a second expansion column 24.
  • Connecting struts 38 of Figures 2 A and 2B are formed from two linear sections, a first linear section 54 being joined at its distal end to a second linear section 56 at its proximal end to form a first slant angle 58.
  • the first linear section 54 of a connecting strut 38 is joined to expansion strut 28 at the point where joining strut 30 makes narrow angle 48 with expansion strut 28.
  • First linear section 54 extends substantially collinear to joining strut 30 continuing the line of joining strut 30 into the space between expansion columns 24.
  • the distal end of the first linear section 54 is joined to the proximal end of the second linear section 56 forming slant angle 58.
  • Second linear section 56 extends substantially parallel to expansion struts 28 connecting at its distal end to joining strut 30 in an adjacent expansion column 24.
  • the distal end of second linear section 56 attaches to expansion strut 28 at the point where joining strut 30 makes narrow angle 48 with expansion strut 28.
  • joining strut 30 can have a second slant angle with a width that can be the same or different from the width of the first slant angle.
  • Figures 2 A and 2B show connecting struts 38 and joining struts 30 slanted relative to the longitudinal axis of stent 10, with the circumferential direction of the slanted struts alternating from column to adjacent column.
  • Circumferential direction refers to the handedness with which the slanted struts wind about the surface of the stent 10.
  • the circumferential direction of the slant of connecting strut first linear sections 54 in a connecting strut column 26 is opposite the circumferential direction of the slant of connecting strut first linear sections 54 in an adjacent connecting strut column 26.
  • the circumferential direction of the slant of joining struts 30 in an expansion column 24 is opposite the circumferential direction of the slant of joining struts 30 in an adjacent expansion column 24.
  • Alternating circumferential slant directions of connecting struts 38 and joining struts 30 prevents axial warping of stent 10 during deliver and expansion.
  • Other non-alternating slant direction patterns can also be used for connecting struts 38 or joining struts 30 or both.
  • Figure 3 A and 3B show a schematic illustration of a stent design according to the present invention in an unexpanded and expanded state respectively.
  • the design is depicted as a flat projection, as if stent 10 were cut lengthwise parallel to its longitudinal axis and flattened out.
  • the connecting struts 38 consist of first and second linear sections 54 and 56 forming slant angle 58 at pivot point 60.
  • An asymmetrical cell space 40 is formed by expansion strut pairs 32, connecting struts 38 and joining struts 30. Multiple interlocking asymmetrical cell spaces 40 make up the design pattern.
  • the expansion strut pairs 32 spread apart at their open ends 36, shortening the length of expansion struts 28 along the longitudinal axis of the cylindrical stent.
  • the longitudinal shortening of expansion struts 28 during expansion is countered by the longitudinal lengthening of connecting struts 38.
  • the widening of slant angle 58 during expansion straightens connecting struts 38 and lengthens the distance between the coupled expansion strut pairs 32.
  • the lengthening of the distance between coupled expansion strut pairs 32 substantially compensates for the longitudinal shortening of expansion struts 28.
  • the stent has substantially constant unexpanded and expanded longitudinal lengths.
  • each expansion column 24 becomes circumferentially stretched, enlarging the space between struts.
  • the interlinking of expansion columns 24 by connecting struts 38 that have been straightened through the expansion process gives the stent 10 a high radial support strength.
  • the entire stent 10 when expanded is unitized into a continuous chain mesh of stretched expansion columns 24 and connecting strut columns 26 forming an asymmetrical interlocking cell geometry which resists collapse both axially and radially. When the stent is expanded it has increased rigidity and fatigue tolerance.
  • connecting struts 38 at pivot points 60 allows increased longitudinal flexibility of the stent.
  • the tangent plane of a specific connecting strut 38 refers to the plane substantially tangent to the cyllindrical surface of the stent at that connecting strut 38.
  • the width of connecting struts 38 is typically two to four, or more times the thickness, which makes connecting struts 38 relatively inflexible when bending in their tangent plane.
  • pivot points 60 in connecting struts 38 provide connecting struts 38 a flexible joint about which to more easily bend increasing longitudinal flexibility of the stent.
  • stent 10 has a length 16 of 33.25 mm and an uncrimped and unexpanded circumference 88 of
  • expansion columns 24 are interspersed with connecting strut columns 26.
  • Each expansion column 24 consists of twelve expansion struts 28 joined alternately at their proximal and distal ends by joining struts 30 forming six expansion strut pairs 32.
  • Expansion struts 28 are aligned parallel to the longitudinal axis of cylindrical stent 10. Joining struts 30 form a narrow angle
  • Adjacent expansion columns 24 employ alternating circumferential slant directions of joining struts 30.
  • expansion strut width 62 is .20 mm
  • expansion strut length 64 is 1.51 mm
  • connecting strut width 66 is .13 mm.
  • Distance 68 from the outer edge of a first expansion strut 28 to the outer edge of a second adjacent expansion strut 28 in the same expansion column 24 is .64 mm, leaving a loop slot width 70 of .24 mm.
  • connecting struts 38 consist of a slanted first linear section 54 joined to a second linear section 56 at a slant angle 58.
  • First linear section 54 is slightly longer than second linear section 56 and is attached at its proximal end to an expansion strut 28 in an expansion column 24. The attachment of the proximal end of first linear section 54 to expansion strut 28 is at the point where joining strut 30 makes narrow angle 48 with expansion strut 28.
  • First linear section 54 extends substantially collinear to joining strut 30 attaching at its distal end to the proximal end of second linear section 56 to form slant angle 58.
  • Second linear section 56 extends substantially collinear to expansion struts 28, attaching at its distal end to an expansion strut 28 in an adjacent expansion column 24. The attachment occurs at the point where expansion strut 28 forms narrow angle 48 with joining strut 30. Joining struts 30 and connecting strut first linear sections 54 slant in alternating circumferential directions from column to adjacent column.
  • connecting struts 38 and expansion struts 28 at the point where narrow angle 48 is formed aids smooth delivery of stent 10 by streamlining the surface of the unexpanded stent and minimizing possible catching points. Bare delivery of stent 10 to the target lesion in a vessel will thus result in minimal snagging or catching as it is navigated through turns and curvatures in the vessel. Stent 10 behaves like a flexible, tubular sled as it is moved forward or backward in the vessel on the delivery catheter, sliding through tortuous vessels and over irregular bumps caused by atherosclerotic plaques inside the vessel lumen.
  • Stent 10 of Figures 4A and 4B has an internal diameter of up to 5.0 mm, while maintaining an acceptable radial strength and fatigue tolerance.
  • the crimped stent outer diameter can be as small as 1.0 mm or less depending on the condition of the underlying delivery balloon profile; A small crimped outer diameter is especially important if stent delivery is to be attempted without predilation of the target site.
  • the surface of the crimped stent is smooth allowing for no snagging of the stent struts during either forward or backward movement through a vessel.
  • Figure 5 shows a second embodiment of the present invention in which the stent 10 in its expanded form has a gradual taper from proximal end 12 to distal end 14.
  • the shaded segments 72, 74, 76, 78, 80, 82 and 84 of expansion struts 28 represent regions of expansion struts 28 to be removed. Removal of the shaded segments 72, 74, 76, 78, 80, 82 and 84 provides stent 10 with a gradual taper when expanded with distal end 14 having a smaller expanded diameter than proximal end 12.
  • the degree of shortening of the expanded diameter of the stent 10 at a given expansion column 24 will be proportional to the length of the removed segment 72, 74, 76, 78, 80, 82, or 84 at that expansion column 24.
  • the shortened expansion struts 28 will have a shortened component along the circumference of the stent resulting in a shortened circumference and diameter.
  • the tapered diameter portion can be positioned anywhere along the length of stent 10, and the tapering can be made more or less gradual by removing appropriately larger or smaller portions of the expansion struts 28 in a given expansion column 24. Tapering is especially important in long stents, longer than 12 mm, since tapering of blood vessels is more pronounced over longer lengths.
  • a long stent with a uniform stent diameter can only be matched to the target vessel diameter over a short region. If the proximal vessel size is matched with the stent diameter, the expanded distal end of the stent will be too large for the natural vessel and may cause an intimal dissection of the distal vessel by stent expansion. On the other hand, if the distal vessel size is matched with the stent diameter, the proximal end of the expanded stent will be too small to set inside the vessel lumen. It is therefore desirable to have a stent with a tapered expanded diameter.
  • Another way achieve a tapered expanded stent is to change the stiffness of the stent struts, expansion struts, connecting struts or joining struts such that the stiffness of the struts varies along the length of the stent.
  • the stiffness of the struts can be changed by altering length, width or thickness, adding additional stiffening material, using a chemical or mechanical means to alter the physical properties of the stent material, or applying one or a series of elastic elements about the stent.
  • a matching tapered balloon catheter would ideally be made for delivery and deployment of the tapered diameter stent.
  • the method of using a tapered matching balloon catheter with a tapered diameter stent is within the scope of the present invention.
  • Using a tapered balloon to expand a non-tapered stent will also achieve a tapered expanded stent; however, since no metal is removed from the stent, the stent is tapered as a result of incomplete expansion.
  • the stent will therefore have increased metal fraction at the tapered end resulting in increased risk of acute thrombosis.
  • Metal fraction is the proportion of the surface of the expanded stent covered by the stent strut material. Shortening the expansion struts as shown in Figure 5 allows for a tapered expanded stent with substantially constant metal fraction along its length.
  • a third embodiment of the present invention shown in Figures 6 A and 6B has multiple reenforcement expansion columns 86 placed along the length of the stent 10.
  • the reenforcement columns 86 are placed along the stent length to provide additional localized radial strength and rigidity to stent 10. Additional strength and rigidity are especially important at the ends of the stent to prevent deformation of the stent both during delivery and after placement. During delivery the stent ends can catch on the vessel wall possibly deforming the unexpanded stent and altering its expansion characteristics.
  • the stent ends are rigid so that they set firmly against the vessel wall; otherwise, during a subsequent catheter procedure, the catheter or guidewire can catch on the stent ends pulling the stent away from the vessel wall and possibly damaging and/or blocking the vessel.
  • the specific variation of the third embodiment of stent 10 depicted in Figures 6A and 6B has a length 16 of 20.70 mm and an uncrimped and unexpanded circumference 88 of 5.26 mm.
  • the stent 10 consists of six expansion columns 24 and three reenforcement expansion columns 86, each consisting respectively of twelve expansion struts 28 or reenforcement expansion struts 90.
  • the reenforcement expansion columns 86 are positioned one at either end, and one along the length of the stent 10.
  • the expansion strut width 62 is .15 mm
  • reenforcement expansion strut width 92 is .20 mm
  • the connecting strut width 66 is .10 mm.
  • the narrow angle 48 formed by joining strut 30 and expansion strut 28 is 75 degrees
  • the narrow angle 94 formed by reenforcement joining strut 96 and reenforcement expansion strut 90 is 60 degrees.
  • reenforcement expansion columns 86 such as providing reenforcement expansion columns 86 only on the ends of the stent, only on one end, or at multiple locations throughout the length of the stent can also be used and fall within the scope of the present invention.
  • a taper can also be programmed into the reenforced stent 10 by shortening expansion struts 28 and reenforcement expansion struts 90 in appropriate expansion columns 24 and 86.
  • a fourth embodiment of the present invention is similar to the third embodiment but has the added feature of relief notches 98 and 100.
  • a relief notch is a notch where metal has been removed from a strut, usually at a joint where multiple struts are connected. Relief notches increase flexibility of a strut or joint by creating a thinned, narrow region along the strut or joint.
  • Relief notch 98 is formed at the joint formed between first linear section 54 of connecting strut 38 and expansion strut 28.
  • Relief notch 100 is formed at the joint between second linear section 56 of connecting strut 38 and expansion strut 28. The positioning of the relief notches gives added flexibility to the unexpanded stent. Relief notches can be placed at other joints and can be included in any of the previously mentioned embodiments.
  • Figures 8 A, 8B, 8C, 8D and 8E illustrates some examples of alternate connecting strut designs which can be used in any of the previously discussed embodiments.
  • Figure 8 A shows a rounded loop connecting strut 38 which joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30. Joining struts 30 are slanted such as to form a narrow angle 48 and a wide angle 50 with the expansion struts 28 they connect.
  • the rounded loop connecting strut 38 connects expansion struts 28 at the point where narrow angle is formed between expansion strut 28 and joining strut 30.
  • the slopes of the rounded connecting strut 38 at its proximal end 102 and distal end 104 substantially match the slopes of the joining struts 30 connecting the pairs of expansion struts 28.
  • the rounded loop connecting strut 38 thus blends smoothly into the joining struts 30.
  • the rounded loop connecting strut 38 has a first radius of curvature 106 and a second radius of curvature 108.
  • a rounded loop connecting strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut
  • Joining struts 30 are at right angles to the expansion struts 28 they connect.
  • the rounded loop connecting strut 38 connects to expansion struts 28 at the same point as joining struts 30.
  • the rounded connecting strut 38 has a first radius of curvature 106 and a second radius of curvature 108 such that it connects circumferentially offset expansion strut pairs 32.
  • connecting strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30. Joining struts 30 are slanted such as to form a narrow angle 48 and a wide angle 50 with the expansion struts 28 they connect.
  • the connecting strut 38 connects expansion struts 28 at the point where narrow angle 48 is formed between expansion strut 28 and joining strut 30.
  • the connecting strut 38 is made up of three linear sections 110, 112, and 114 forming two slant angles 116 and 118.
  • the proximal end of section 110 is attached to expansion strut 28 at the point where joining strut 30 forms narrow angle 48 with expansion strut 28.
  • Section 110 extends substantially collinear to joining strut 30 and is attached at its distal end to section 112 forming slant angle 116.
  • Section 112 extends at an angle to section 110 such that section 112 is substantially parallel to expansion struts 28 and is connected at its distal end to the proximal end of section 114 forming slant angle 118.
  • Section 114 extends at an angle such that it is substantially collinear to joining strut 30 of the adjacent expansion strut pair 32.
  • Section 114 attaches at its distal end to expansion strut 28 of the adjacent expansion strut pair 32, at the point where joining strut 30 forms narrow angle 48 with expansion strut 28.
  • a connecting strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30. Joining struts 30 are at right angles to the expansion struts 28 they connect. The connecting strut 38 connects to expansion struts 28 at the same point as joining struts 30.
  • the connecting struts 38 of Figures 8D and 8E are made up of multiple connecting strut sections connected end to end to form a jagged connecting strut 38 with multiple slant angles, coupling expansion strut pair 32 to adjacent expansion strut pair 32.
  • the connecting strut of Figure 8D is made up of three connecting strut sections 120, 122, and 124 with two slant angles 126 and 128, while the connecting strut of Figure 8E consists of four connecting strut sections 130, 132, 134, and 136 with three slant angles 138, 140 and 142.
  • connecting strut section 134 can be modified by replacing connecting strut section 136 by the dotted connecting strut section 144 to give another possible geometry of connecting struts 38.
  • connecting struts and joining struts consistent with the present invention; the above examples are not intended to be an exhaustive list.
  • the stent of the present invention is ideally suited for application in coronary vessels although versatility in the stent design allows for applications in non-coronary vessels, the aorta, and nonvascular tubular body organs.
  • Typical coronary vascular stents have expanded diameters that range from 2.5 to 5.0 mm.
  • a stent with high radial strength and fatigue tolerance that expands to a 5.0 mm diameter may have unacceptably high stent metal fraction when used in smaller diameter vessels. If the stent metal fraction is high, the chances of acute thrombosis and restenosis potential will increase. Even with the same metal fraction a smaller caliber vessel is more likely than a larger one to have a high rate of thrombosis.
  • stents for coronary application for example, small vessels stents for use in vessels with diameters from 2.5 mm to 3.0 mm, and large vessel stents for use in vessels with diameters from 3.0 mm to 5.0 mm.
  • the stent of the present invention can be made using a CAM-driven laser cutting system to cut the stent pattern from a stainless steel tube.
  • the rough-cut stent is preferably electro-polished to remove surface imperfections and sharp edges.
  • Other methods of fabricating the stent can also be used such as EDM, photo-electric etching technology, or other methods. Any suitable material can be used for the stent including other metals and polymers so long as they provide the essential structural strength, flexibility, biocompatibility and expandability.
  • the stent is typically at least partially plated with a radiopaque metal, such as gold, platinum, tantalum or other suitable metal. It is preferred to plate only both ends of the stent by localized plating; however, the entire stent or other regions can also be plated. When plating both ends, one to three or more expansion columns on each end of the stent are plated to mark the ends of the stent so they can be identified under fluoroscopy during the stenting procedure. By plating the stent only at the ends, interference of the radiopaque plating material with performance characteristics or surface modulation of the stent frame is minimized. Additionally the amount of plating material required is reduced, lowering the material cost of the stent.
  • a radiopaque metal such as gold, platinum, tantalum or other suitable metal.
  • the stent is cleaned, typically with detergent, saline and ultrasonic means that are well-known in the art.
  • the stents are then inspected for quality control, assembled with the delivery balloon catheter, and properly packaged, labeled, and sterilized.
  • the stent can be marketed as stand alone or as a pre-mounted delivery balloon catheter assembly as shown in Figure 9.
  • the stent 10 is crimped over a folded balloon 146 at the distal end 148 of a delivery balloon catheter assembly 150.
  • the assembly 150 includes a proximal end adapter 152, a catheter shaft 154, a balloon channel 156, a guidewire channel 158, a balloon 146, and a guidewire 160.
  • Balloon 146 can be tapered, curved, or both tapered and curved from a proximal end to a distal end in the expanded state. Additionally stent 10 can be non-tapered or tapered in the expanded state.
  • the guidewire 160 is inserted into the vein or artery and advanced to the target site.
  • the catheter shaft 154 is then forwarded over the guidewire 160 to position the stent 10 and balloon 146 into position at the target site.
  • the balloon 146 is inflated through the balloon channel 156 to expand the stent 10 from a crimped to an expanded state.
  • the stent 10 provides the desired scaffolding support to the vessel.
  • the balloon 146 is deflated and the catheter shaft 154, balloon 146, and guidewire 160 are withdrawn from the patient.
  • the stent of the present invention can be made as short as less than 10 mm in length or as long as 100 mm or more. If long stents are to be used, however, matching length delivery catheter balloons will typically be needed to expand the stents into their deployed positions. Long stents, depending on the target vessel, may require curved long balloons for deployment. Curved balloons which match the natural curve of a blood vessel reduce stress on the blood vessel during stent deployment. This is especially important in many coronary applications which involve stenting in curved coronary vessels. The use of such curved balloons is within the scope of the present invention.
  • the foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.

Abstract

Contracté, cet extenseur possède une première paire de tiges de dilatation de montant. Un premier montant de dilatation est formé par plusieurs paires de tiges de dilatation de montant et un second montant de dilatation est formé par plusieurs paires de tiges de dilatation de montant. Plusieurs premières tiges de connexion en série forment un premier montant de tiges de liaison qui relie le premier montant de dilatation au second. Le premier et le second montant de dilatation ainsi que le premier montant de tiges de liaison constituent plusieurs cellules géométriques dont quelques unes, au moins, sont asymétriques.
PCT/US1998/005835 1997-03-25 1998-03-25 Extenseur intravasculaire WO1998042277A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU65839/98A AU6583998A (en) 1997-03-25 1998-03-25 Intravascular stent
JP54594498A JP4046773B2 (ja) 1997-03-25 1998-03-25 脈管内ステント
EP98912026A EP0971644A1 (fr) 1997-03-25 1998-03-25 Extenseur intravasculaire

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/826,866 1997-03-25
US08/824,142 1997-03-25
US08/824,865 US6152957A (en) 1996-04-26 1997-03-25 Intravascular stent
US08/824,865 1997-03-25
US08/824,142 US6241760B1 (en) 1996-04-26 1997-03-25 Intravascular stent
US08/824,866 US5954743A (en) 1996-04-26 1997-03-25 Intravascular stent

Publications (1)

Publication Number Publication Date
WO1998042277A1 true WO1998042277A1 (fr) 1998-10-01

Family

ID=27420163

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US1998/005835 WO1998042277A1 (fr) 1997-03-25 1998-03-25 Extenseur intravasculaire
PCT/US1998/005856 WO1998042278A1 (fr) 1997-03-25 1998-03-25 Extenseur intravasculaire

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US1998/005856 WO1998042278A1 (fr) 1997-03-25 1998-03-25 Extenseur intravasculaire

Country Status (4)

Country Link
EP (2) EP1011530A1 (fr)
JP (3) JP4015204B2 (fr)
AU (2) AU6583998A (fr)
WO (2) WO1998042277A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799363A1 (fr) * 1999-10-11 2001-04-13 Braun Celsa Sa Implant medical a meandres en zigzag
EP1871288A2 (fr) * 2004-06-08 2008-01-02 Tini Alloy Company Dispositifs tridimensionnels auto-deployables et escamotables et procedes de fabrication
EP2529707A1 (fr) * 2002-05-08 2012-12-05 Abbott Laboratories Endoprothèse présentant des extensions de base
US8584767B2 (en) 2007-01-25 2013-11-19 Tini Alloy Company Sprinkler valve with active actuation
US8915954B2 (en) 2003-05-06 2014-12-23 Abbott Laboratories Endoprosthesis having foot extensions
US10124197B2 (en) 2012-08-31 2018-11-13 TiNi Allot Company Fire sprinkler valve actuator
US10610620B2 (en) 2007-07-30 2020-04-07 Monarch Biosciences, Inc. Method and devices for preventing restenosis in cardiovascular stents
US11040230B2 (en) 2012-08-31 2021-06-22 Tini Alloy Company Fire sprinkler valve actuator

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4636634B2 (ja) 1996-04-26 2011-02-23 ボストン サイエンティフィック サイムド，インコーポレイテッド 脈管内ステント
US6235053B1 (en) 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US20040106985A1 (en) 1996-04-26 2004-06-03 Jang G. David Intravascular stent
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
JP2009542359A (ja) 2006-06-29 2009-12-03 ボストン サイエンティフィック リミテッド 選択的被覆部を備えた医療装置
JP2010503469A (ja) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド 薬物溶出性皮膜を有する医療デバイス
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US9284409B2 (en) 2007-07-19 2016-03-15 Boston Scientific Scimed, Inc. Endoprosthesis having a non-fouling surface
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
WO2009018340A2 (fr) 2007-07-31 2009-02-05 Boston Scientific Scimed, Inc. Revêtement de dispositif médical par placage au laser
JP2010535541A (ja) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド 広い表面積を有する医療器具用のコーティング
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
EP2271380B1 (fr) 2008-04-22 2013-03-20 Boston Scientific Scimed, Inc. Dispositifs médicaux revêtus d une substance inorganique
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US8449603B2 (en) 2008-06-18 2013-05-28 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587197A1 (fr) * 1990-10-13 1994-03-16 Angiomed Ag Dispositif d'agencement dans un conduit corporel
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
EP0679372A2 (fr) * 1994-04-25 1995-11-02 Advanced Cardiovascular Systems, Inc. Marqueurs radiopaques pour stent
EP0709067A2 (fr) * 1994-10-27 1996-05-01 Medinol Limited Procédé de fabrication d'un extenseur
DE29608037U1 (de) * 1996-05-03 1996-07-11 Sitomed Gmbh Koronarer Stent
WO1996026689A1 (fr) * 1995-03-01 1996-09-06 Scimed Life Systems, Inc. Extenseur dilatable a flexibilite longitudinale amelioree
WO1997040780A1 (fr) * 1996-04-26 1997-11-06 Jang G David Prothese endovasculaire

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2026604A1 (fr) * 1989-10-02 1991-04-03 Rodney G. Wolff Drain articule
GR1002388B (el) * 1993-01-06 1996-07-03 Ethicon Inc. Διαστολεας.
US5733303A (en) * 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
JPH11501551A (ja) * 1995-04-26 1999-02-09 メディノール リミティド 関節のあるステント
JP4636634B2 (ja) * 1996-04-26 2011-02-23 ボストン サイエンティフィック サイムド，インコーポレイテッド 脈管内ステント
FR2749500B1 (fr) * 1996-06-06 1998-11-20 Jacques Seguin Dispositif permettant le traitement de conduits corporels au niveau d'une bifurcation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587197A1 (fr) * 1990-10-13 1994-03-16 Angiomed Ag Dispositif d'agencement dans un conduit corporel
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
EP0679372A2 (fr) * 1994-04-25 1995-11-02 Advanced Cardiovascular Systems, Inc. Marqueurs radiopaques pour stent
EP0709067A2 (fr) * 1994-10-27 1996-05-01 Medinol Limited Procédé de fabrication d'un extenseur
WO1996026689A1 (fr) * 1995-03-01 1996-09-06 Scimed Life Systems, Inc. Extenseur dilatable a flexibilite longitudinale amelioree
WO1997040780A1 (fr) * 1996-04-26 1997-11-06 Jang G David Prothese endovasculaire
DE29608037U1 (de) * 1996-05-03 1996-07-11 Sitomed Gmbh Koronarer Stent

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799363A1 (fr) * 1999-10-11 2001-04-13 Braun Celsa Sa Implant medical a meandres en zigzag
EP1092401A1 (fr) * 1999-10-11 2001-04-18 B. Braun Medical Société Anonyme Stent en hélice
US6620201B1 (en) 1999-10-11 2003-09-16 B. Braun Medical One piece medical prosthesis for an anatomical duct
EP2529707A1 (fr) * 2002-05-08 2012-12-05 Abbott Laboratories Endoprothèse présentant des extensions de base
US8915954B2 (en) 2003-05-06 2014-12-23 Abbott Laboratories Endoprosthesis having foot extensions
EP1871288A2 (fr) * 2004-06-08 2008-01-02 Tini Alloy Company Dispositifs tridimensionnels auto-deployables et escamotables et procedes de fabrication
EP1871288A4 (fr) * 2004-06-08 2012-10-10 Tini Alloy Co Dispositifs tridimensionnels auto-deployables et escamotables et procedes de fabrication
US8584767B2 (en) 2007-01-25 2013-11-19 Tini Alloy Company Sprinkler valve with active actuation
US10610620B2 (en) 2007-07-30 2020-04-07 Monarch Biosciences, Inc. Method and devices for preventing restenosis in cardiovascular stents
US10124197B2 (en) 2012-08-31 2018-11-13 TiNi Allot Company Fire sprinkler valve actuator
US11040230B2 (en) 2012-08-31 2021-06-22 Tini Alloy Company Fire sprinkler valve actuator

Also Published As

Publication number Publication date
WO1998042278A1 (fr) 1998-10-01
EP1011530A1 (fr) 2000-06-28
JP4885041B2 (ja) 2012-02-29
AU6584498A (en) 1998-10-20
JP2002523009A (ja) 2002-07-23
JP4015204B2 (ja) 2007-11-28
JP2007216042A (ja) 2007-08-30
JP4046773B2 (ja) 2008-02-13
AU6583998A (en) 1998-10-20
EP0971644A1 (fr) 2000-01-19
JP2002515810A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
EP0907339B1 (fr) Prothese endovasculaire
US5954743A (en) Intravascular stent
US9078778B2 (en) Intravascular stent
US5922021A (en) Intravascular stent
EP0927006B1 (fr) Prothese endovasculaire
EP0971644A1 (fr) Extenseur intravasculaire
WO1998048735A1 (fr) Extenseur intravasculaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN JP KR SG

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998912026

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998912026

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998912026

Country of ref document: EP